We found that 53.71% of all bladder cancer samples showed genetic mutations in the TCGA bladder cancer cohort and SCAF11 was the most frequent mutation frequency gene, followed by CASP8 and NLRP7 (Figure 1B). This evidence concerns the gene SCAF11 and urinary bladder carcinoma.